VivoSim Labs, Inc. (VIVS) intrinsic value & 10-year financials
VivoSim Labs, Inc. (VIVS) has a Graham intrinsic value of $54.50 per share. At $0.16 on Oct 17, 2026, the stock trades 100% below that value. Over the last 10 fiscal years revenue shrank 22.8% a year to $144.0K, with an average return on invested capital of 2174.6%.
- Graham intrinsic value
- $54.50
- Share price (Oct 17, 2026)
- $0.16
- Price vs Graham value
- 100% below
- Market cap
- $234.2K
- Revenue (FY2025)
- $144.0K
- Revenue growth (10-yr CAGR)
- -22.8%
- ROIC (10-yr avg)
- 2174.6%
- Free cash flow (FY2025)
- -$9.5M
VIVS 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $144.0K | -$2.5M | -$1.70 | -$9.5M | -8761.1% | -2122.1% |
| FY2024 | $109.0K | -$14.7M | -$1.60 | -$14.7M | -13840.4% | -1030.1% |
| FY2023 | $370.0K | -$17.3M | -$1.98 | -$12.8M | -4792.2% | -774.4% |
| FY2022 | $1.5M | -$11.4M | -$1.32 | -$8.9M | -765.3% | -452.8% |
| FY2021 | $0 | -$16.8M | — | -$13.7M | — | -918.4% |
| FY2020 | $2.2M | -$18.7M | — | -$14.9M | -977.9% | 11997.2% |
| FY2019 | $3.1M | -$26.6M | — | -$20.5M | -882.4% | 15236.9% |
| FY2018 | $4.6M | -$34.8M | — | -$29.1M | -766.3% | -66.0% |
| FY2017 | $4.2M | -$38.4M | — | -$30.5M | -911.9% | -61.9% |
| FY2016 | $1.5M | -$38.6M | — | -$31.5M | -2605.7% | -62.1% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
VivoSim Labs, INC. is facing top-line stagnation, with revenue contracting over the decade.
VivoSim Labs, INC. has historically struggled to out-earn its cost of capital, averaging just 2.9% ROIC.
VivoSim Labs, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, VivoSim Labs, INC. is modeled at -22.8% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $54.50 per share.